Pilar Retamar

5.0k total citations
34 papers, 1.2k citations indexed

About

Pilar Retamar is a scholar working on Applied Microbiology and Biotechnology, Pharmacology and Epidemiology. According to data from OpenAlex, Pilar Retamar has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Applied Microbiology and Biotechnology, 12 papers in Pharmacology and 12 papers in Epidemiology. Recurrent topics in Pilar Retamar's work include Antibiotic Use and Resistance (17 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Pilar Retamar is often cited by papers focused on Antibiotic Use and Resistance (17 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Pilar Retamar collaborates with scholars based in Spain, Italy and France. Pilar Retamar's co-authors include Jesús Rodríguez‐Baño, Álvaro Pascual, M.D. Navarro, Alfonso del Arco, María Dolores López-Prieto, Andrés Martín-Aspas, A Arroyo, Juan E. Corzo, Ángel Muñiz Muñoz and Marina de Cueto and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and FEMS Microbiology Reviews.

In The Last Decade

Pilar Retamar

31 papers receiving 1.2k citations

Peers

Countries citing papers authored by Pilar Retamar

Since Specialization

Citations

This map shows the geographic impact of Pilar Retamar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilar Retamar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilar Retamar more than expected).

Fields of papers citing papers by Pilar Retamar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pilar Retamar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilar Retamar. The network helps show where Pilar Retamar may publish in the future.

Co-authorship network of co-authors of Pilar Retamar

This figure shows the co-authorship network connecting the top 25 collaborators of Pilar Retamar. A scholar is included among the top collaborators of Pilar Retamar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pilar Retamar. Pilar Retamar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Examining tailoring as an implementation strategy for reducing healthcare-associated infections across European acute care hospitals (REVERSE): study protocol for a hybrid type 2 effectiveness-implementation trial 2025 ·Trials ·Bianca Albers, (unknown), (unknown), Greet J. Boland, Elena Carrara, Pilar Retamar, Aude Nguyen, (unknown), Vered Schechner, (unknown), Takuya Yanagida, Walter Zingg, (unknown)	0
2	Antibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions: A prospective multicentre cohort (NO-BACT) 2023 ·Journal of Infection ·(unknown), (unknown), (unknown), Fátima Galán‐Sánchez, (unknown), (unknown), Marina de Cueto, (unknown), Zaira R. Palacios‐Baena, Silvia Jiménez‐Jorge, Jesús Rodríguez‐Baño, Pilar Retamar	1
3	Management of patients with suspected or confirmed antibiotic allergy. Executive summary of guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC) 2023 ·Enfermedades infecciosas y microbiologia clinica (English ed ) ·José Ramón Paño‐Pardo, Esther Moreno, (unknown), (unknown), (unknown), José Luís del Pozo, Pilar Retamar, (unknown), Marı́a José Torres, (unknown), (unknown)	2
4	Management of Patients with Suspected or Confirmed Antibiotic Allergy: Executive Summary of Guidelines from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC) 2022 ·Journal of Investigational Allergology and Clinical Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Pilar Retamar, (unknown), (unknown), (unknown), (unknown)	8
5	Predictors of inappropriate antimicrobial prescription: Eight-year point prevalence surveys experience in a third level hospital in Spain 2022 ·Frontiers in Pharmacology ·María Núñez‐Núñez, Salvador Pérez-Galera, (unknown), (unknown), (unknown), Marina de Cueto, (unknown), Zaira R. Palacios‐Baena, (unknown), (unknown), (unknown), Jesús Rodríguez‐Baño, Pilar Retamar	3
6	Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project 2020 ·BMJ Open ·Zaira R. Palacios‐Baena, (unknown), (unknown), Clara Rosso-Fernández, (unknown), (unknown), (unknown), (unknown), Andrés Martín-Aspas, (unknown), Juan José Castón, (unknown), Guillermo Ojeda, (unknown), (unknown), (unknown), (unknown), Jesús Rodríguez‐Baño, Pilar Retamar	0
7	Opportunities for antibiotic optimisation and outcome improvement in patients with negative blood cultures: study protocol for a cluster-randomised crossover trial, the NO-BACT study 2019 ·BMJ Open ·Silvia Jiménez‐Jorge, Zaira R. Palacios‐Baena, Clara Rosso-Fernández, (unknown), Jesús Rodríguez‐Baño, Pilar Retamar	1
8	Análisis de la calidad de uso de antimicrobianos en el servicio de urgencias de un hospital de tercer nivel. 2018 ·Emergencias ·(unknown), María Núñez‐Núñez, (unknown), (unknown), Jesús Rodríguez‐Baño, Pilar Retamar	6
9	Management of bloodstream infections by infection specialists: an international ESCMID cross-sectional survey 2018 ·International Journal of Antimicrobial Agents ·(unknown), Nathalie Thilly, (unknown), Guillaume Béraud, Önder Ergönül, Maddalena Giannella, Diamantis P. Kofteridis, Tomislav Kostyanev, José Ramón Paño‐Pardo, Pilar Retamar, Winfried V. Kern, C. Pulcini	42
10	Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial 2017 ·BMJ Open ·Luis Eduardo López-Cortés, Clara Rosso-Fernández, María Núñez‐Núñez, (unknown), José María Bravo-Ferrer, (unknown), Mercedes Delgado-Valverde, (unknown), Pilar Retamar, Jesús Rodríguez‐Baño	5
11	Escherichia coli: an old friend with new tidings 2016 ·FEMS Microbiology Reviews ·Jordi Vilà, Emma Sáez-López, James R. Johnson, Ute Römling, Ulrich Dobrindt, Rafael Cantón, Christian G. Giske, Thierry Naas, Alessandra Carattoli, Margarita Martínez-Medina, Jordi Bosch, Pilar Retamar, Jesús Rodríguez‐Baño, Fernando Baquero, Sara M. Soto	236
12	Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology 2015 ·Enfermedades Infecciosas y Microbiología Clínica ·Jesús Rodríguez‐Baño, José Miguel Cisneros, Nazaret Cobos-Trigueros, Gema Fresco, Carolina Navarro-San Francisco, Carlota Gudiol, Juan Pablo Horcajada, Lorena López‐Cerero, José Antonio Martínez, José Molina, M. Montero, José Ramón Paño‐Pardo, Álvaro Pascual, Carmen Peña, Vicente Pintado, Pilar Retamar, María Tomás, Marcío Borges-Sa, José Garnacho‐Montero, Germán Bou	33
13	Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia? 2015 ·Journal of Antimicrobial Chemotherapy ·Luis Eduardo López-Cortés, C. Velasco, Pilar Retamar, María Dolores del Toro, Juan Gálvez-Acebal, Marina de Cueto, Isabel Garcı́a, Francisco J. Caballero, Álvaro Pascual, Jesús Rodríguez‐Baño	16
14	Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) 2015 ·Enfermedades Infecciosas y Microbiología Clínica ·Jesús Rodríguez‐Baño, José Miguel Cisneros, Nazaret Cobos-Trigueros, Gema Fresco, Carolina Navarro-San Francisco, Carlota Gudiol, Juan Pablo Horcajada, Lorena López‐Cerero, José Antonio Martínez, José Molina, M. Montero, José Ramón Paño‐Pardo, Álvaro Pascual, Carmen Peña, Vicente Pintado, Pilar Retamar, María Tomás, Marcío Borges-Sa, José Garnacho‐Montero, Germán Bou	22
15	Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: a prospective cohort study 2013 ·BMC Infectious Diseases ·(unknown), Pilar Retamar, María Dolores López-Prieto, C. Natera, Marina de Cueto, Enrique Nuño, Marta Herrero, Fernando Fernández Sánchez, Ángel Muñiz Muñoz, Francisco Téllez, B. Becerril, (unknown), (unknown), Raquel Moya, Juan E. Corzo, (unknown), (unknown), Jesús Rodríguez‐Baño	12
16	Evaluating the quality of antimicrobial prescribing: Is standardisation possible? 2013 ·Enfermedades Infecciosas y Microbiología Clínica ·Pilar Retamar, (unknown), José Molina, Alfonso del Arco	9
17	-Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts 2011 ·Clinical Infectious Diseases ·Jesús Rodríguez‐Baño, M.D. Navarro, Pilar Retamar, (unknown), Álvaro Pascual	270
18	Cefalea y visión borrosa en una mujer de 26 años 2010 ·Medicina Clínica ·José Hernández‐Quero, Pilar Retamar	0
19	Current management of bloodstream infections 2010 ·Expert Review of Anti-infective Therapy ·Jesús Rodríguez‐Baño, Marina de Cueto, Pilar Retamar, Juan Gálvez-Acebal	19
20	Epidemiology and Clinical Features of Community-Acquired, Healthcare Associated and Nosocomial Bloodstream Infections in Tertiary and Community Hospitals 2009 ·Clinical Microbiology and Infection ·Jesús Rodríguez‐Baño, María Dolores López-Prieto, (unknown), Pilar Retamar, C. Natera, Enrique Nuño, Marta Herrero, Alfonso del Arco, Ángel Muñiz Muñoz, Francisco Téllez, M. Torres-Tortosa, Andrés Martín-Aspas, A Arroyo, Ana Isabel Menasalvas, Raquel Moya, Juan E. Corzo, (unknown), (unknown), (unknown)	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact